An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

Hanlim Pharm. Co., Ltd.4,000 enrolled

Overview

This study identify prescription patterns of Lodient Tab and evaluate the changes of the hypertension symptoms (BP pressure) who are first prescribed and taking Lodient Tab.

This study aims to observe changes in symptoms according to the treatment effect of hypertension for 6 months after Lodient Tab prescription.

Study Type

OBSERVATIONAL

Enrollment

4,000

Conditions

Hypertension

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adults over 19 years of age 2. A person diagnosed with hypertension 3. A person who has been first prescribed Lodient Tab within the past 4 months as of the IRB approval date or is scheduled to be prescribed Lodient Tab 4. A person who voluntarily agreed in writing to this study Exclusion Criteria: 1. Pregnant women or nursing mothers 2. Persons subject to prohibition according to the permission of the Lodient Tab 3. Patients who in the judgement of the investigator, were inappropriate to participate in the study

Locations (1)

Seoul song clinic

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

The percentage of patients who met target systolic blood pressure (less than 140mmHg) at 6 months of prescription for Lodient Tab compared to baseline

Time frame: at 6 months of prescription for Lodient Tab compared to baseline

Central Contacts

Minseob Song

CONTACT

+820222737282 song2you@naver.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.